Tenofovir Alafenamide Tablets

DRUG3 trials

Sponsors

Kaohsiung Medical University Chung-Ho Memorial Hospital, Shanghai HEP Pharmaceutical Co., Ltd., First People's Hospital of Hangzhou

Conditions

Chronic Hepatitis BChronic Hepatitis bHBVTenofovir Alafenamide Fumarate

Phase 2

A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients

CompletedNCT05244057

Shanghai HEP Pharmaceutical Co., Ltd.Chronic Hepatitis B

Start: 2022-08-23End: 2024-06-24Updated: 2024-07-15

Phase 4

Tenofovir Alafenamide in HBV Related Decompensated Liver

Kaohsiung Medical University Chung-Ho Memorial HospitalHBV

Start: 2020-09-01End: 2025-04-01Target: 100Updated: 2020-12-24

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

RecruitingNCT05853718

First People's Hospital of HangzhouChronic Hepatitis b, Tenofovir Alafenamide Fumarate

Start: 2021-05-06End: 2025-12-30Target: 50Updated: 2025-09-08